Literature DB >> 2903136

Development and characterization of a human cell line from an ovarian mixed Müllerian tumor (carcinosarcoma).

C van Haaften-Day1, P Russell, S Carr, L Wright.   

Abstract

A cell line derived from a human ovarian carcinosarcoma was established in tissue culture and in nude mice. Two sublines, LDF and HDF, separated by discontinuous density centrifugation were also established from the parent line JoN. The cloning efficiency of the JoN line was 21%. Morphologic features of adenocarcinoma cells characteristic of the parent JoN cells were retained in the sublines and clones; all lines showed the same karyotype and DNA content (pseudodiploid and pseudotetraploid). Keratin, as demonstrated immunohistochemically, was strongly expressed in the parent line JoN and the xenograft tumor, but not at all in the LDF sublines and only moderately in the HDF sublines. Vimentin, however, was expressed in neither the parent line JoN nor the xenograft tumor, but was present in both sublines. Transglutaminase and plasminogen activator activity was high in the parent line JoN. Neither, sublines nor clones showed the same high enzyme activity as the parent line. It is concluded that this human tumor line JoN is comprised of epithelial cells, capable of multidirectional differentiation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903136     DOI: 10.1007/bf02620867

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol        ISSN: 0883-8364


  21 in total

1.  Xenografted small cell undifferentiated cancer of prostate: possible common origin with prostatic adenocarcinoma.

Authors:  C van Haaften-Day; D Raghavan; P Russell; E J Wills; P Gregory; W Tilley; D J Horsfall
Journal:  Prostate       Date:  1987       Impact factor: 4.104

2.  Characteristics of cell lines established from a mixed mesodermal tumor of the human ovary. Carcinomatous cells are changeable to sarcomatous cells.

Authors:  A Masuda; A Takeda; H Fukami; C Yamada; M Matsuyama
Journal:  Cancer       Date:  1987-12-01       Impact factor: 6.860

3.  A rapid single step staining technique for DNA analysis by flow microfluorimetry.

Authors:  I W Taylor
Journal:  J Histochem Cytochem       Date:  1980-09       Impact factor: 2.479

4.  Stimulation of human synovial fibroblast plasminogen activator production by mononuclear cell supernatants.

Authors:  J A Hamilton; J Slywka
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

5.  Separation of epidermal cells by density centrifugation: a new technique for studies on normal and pathological differentiation.

Authors:  S M Fischer; K D Nelson; J J Reiners; A Viaje; J C Pelling; T J Slaga
Journal:  J Cutan Pathol       Date:  1982-02       Impact factor: 1.587

6.  FMFPAK1: a program package for routine analysis of single parameter flow microfluorimetric data on a low cost mini-computer.

Authors:  B Milthorpe
Journal:  Comput Biomed Res       Date:  1980-10

7.  Appearance of plasminogen activator activity during a synchronous cycle of a rat adenocarcinoma cell line, PA-III.

Authors:  F M Scott; V Sator de Serrano; F J Castellino
Journal:  Exp Cell Res       Date:  1987-03       Impact factor: 3.905

8.  Transglutaminase activity increases in HL60 cells induced to differentiate with retinoic acid and TPA but not with DMSO.

Authors:  A M Maddox; M K Haddox
Journal:  Exp Cell Biol       Date:  1985

Review 9.  Plasminogen activator and cancer.

Authors:  M J Duffy; P O'Grady
Journal:  Eur J Cancer Clin Oncol       Date:  1984-05

10.  Differential regulation by retinoic acid and calcium of transglutaminases in cultured neoplastic and normal human keratinocytes.

Authors:  A L Rubin; R H Rice
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  3 in total

1.  Characterization of an HPV-negative cell line (FR-CAR) derived from a cervical squamous intraepithelial lesion.

Authors:  C van Haaften-Day; B Rose; C Thompson; R Lukeis; P Russell
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-10       Impact factor: 2.416

2.  Conventional chemotherapy and oncogenic pathway targeting in ovarian carcinosarcoma using a patient-derived tumorgraft.

Authors:  Gretchen Glaser; S John Weroha; Marc A Becker; Xiaonan Hou; Sergio Enderica-Gonzalez; Sean C Harrington; Paul Haluska
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

3.  Presence of both Mesenchymal and Carcinomatous Features in an In-vitro Model of Ovarian Carcinosarcoma Derived from Patients' Ascitic Fluid.

Authors:  Ahmad Shariftabrizi; Ilenia Pellicciotta; Amer Abdullah; Charis Anne Venditti; Robert Samuelson; Shohreh Shahabi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.